Bayer, Sun Pharma sign marketing and distribution agreement for second brand of Finerenone in India
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Inducts advanced AI-Powered 24x7 remote patient monitoring system
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
A 'better for you' organic brand spanning Food & Beverages and Nutraceutical categories
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
HIFU is a state-of-the-art treatment that utilizes high-frequency sound waves to target and destroy prostate cancer cells
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Subscribe To Our Newsletter & Stay Updated